Literature DB >> 14755449

Evidence of a founder effect in families with frontotemporal dementia that harbor the tau +16 splice mutation.

Stuart Pickering-Brown1, Matt Baker, Thomas Bird, John Trojanowski, Virginia Lee, Huw Morris, Martin Rossor, John C Janssen, David Neary, David Craufurd, Anna Richardson, Julie Snowden, John Hardy, David Mann, Mike Hutton.   

Abstract

The +16 exon 10 splice mutation of the tau gene (microtubule-associated protein tau, MAPT) has been reported in numerous families with frontotemporal dementia (FTD). To date, the majority of these families are from England and Wales in the UK, although families with this mutation have been reported from Australia and the USA. Our own analysis has identified eight families with the +16 MAPT splice mutation from around the Manchester and North Wales areas of the UK. Given the proximity of the UK families to one another it is likely that they are related and represent a single extended pedigree. In order to investigate this possibility, and the possibility that the families with this mutation from London, the USA, and Australia are related, we genotyped 11 microsatellite markers around the tau locus. In most cases (20/25, 80%), a common haplotype, approximately 3 cM in size, was identified. In the remaining cases, this haplotype appears to have been varyingly reduced in size by recombination. We demonstrate that the +16 mutation is on the H1 tau haplotype and that H1 specific polymorphisms are also shared by these families. These data provide evidence that the MAPT +16 splice mutation cases from around the world analyzed in this study are indeed related and represent a single pedigree that probably originated in the North Wales area of the UK. Furthermore, this single large pedigree may be of use in the identification of disease modifying loci in FTD. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14755449     DOI: 10.1002/ajmg.b.20083

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  5 in total

1.  The apolipoprotein E epsilon4 allele selectively increases the risk of frontotemporal lobar degeneration in males.

Authors:  R Srinivasan; Y Davidson; L Gibbons; A Payton; A M T Richardson; A Varma; C Julien; C Stopford; J Thompson; M A Horan; N Pendleton; S M Pickering-Brown; D Neary; J S Snowden; D M A Mann
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-02       Impact factor: 10.154

2.  The heritability and genetics of frontotemporal lobar degeneration.

Authors:  J D Rohrer; R Guerreiro; J Vandrovcova; J Uphill; D Reiman; J Beck; A M Isaacs; A Authier; R Ferrari; N C Fox; I R A Mackenzie; J D Warren; R de Silva; J Holton; T Revesz; J Hardy; S Mead; M N Rossor
Journal:  Neurology       Date:  2009-11-03       Impact factor: 9.910

3.  Searching for Grendel: origin and global spread of the C9ORF72 repeat expansion.

Authors:  Hannah A Pliner; David M Mann; Bryan J Traynor
Journal:  Acta Neuropathol       Date:  2014-02-05       Impact factor: 17.088

4.  Recent origin and spread of a common Welsh MAPT splice mutation causing frontotemporal lobar degeneration.

Authors:  Roberto Colombo; Daniela Tavian; Matthew C Baker; Anna M T Richardson; Julie S Snowden; David Neary; David M A Mann; Stuart M Pickering-Brown
Journal:  Neurogenetics       Date:  2009-04-14       Impact factor: 2.660

5.  [18F]AV-1451 PET in behavioral variant frontotemporal dementia due to MAPT mutation.

Authors:  W Richard Bevan Jones; Thomas E Cope; Luca Passamonti; Tim D Fryer; Young T Hong; Franklin Aigbirhio; Jillian J Kril; Shelley L Forrest; Kieren Allinson; Jonathan P Coles; P Simon Jones; Maria G Spillantini; John R Hodges; John T O'Brien; James B Rowe
Journal:  Ann Clin Transl Neurol       Date:  2016-10-18       Impact factor: 4.511

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.